Dive Brief: Regeneron has agreed to purchase a young biotechnology company for access to a drug that the buyer believes will be a valuable component …
Dive Brief: Through a deal announced Wednesday, a German-based biotechnology company has agreed to help Regeneron develop a gene therapy for an inherited retinal disease. …
Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has officially opened its new facilities at Charnwood Campus, Loughborough. …
Dive Brief: On the heels of a recent setback, Yumanity Therapeutics, a biotechnology company focused on neuroscience, plans to eliminate about 60% of its workforce …
Dive Brief: Editas Medicine, a biotechnology company focused on CRISPR gene editing, has fired its chief medical officer, adding to a series of executive-level change-ups …
